当前位置:首页 - 行情中心 - 北陆药业(300016) - 财务分析 - 现金流量表

北陆药业

(300016)

  

流通市值:45.44亿  总市值:45.49亿
流通股本:5.81亿   总股本:5.82亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,157,084,244.18749,505,093.69367,006,602.031,201,156,280.74
  收到的税费返还3,512,770.83,512,770.83,576,447.836,901,631.48
  收到其他与经营活动有关的现金8,555,799.256,310,813.262,430,358.7323,744,722.03
  经营活动现金流入小计1,169,152,814.23759,328,677.75373,013,408.591,231,802,634.25
  购买商品、接受劳务支付的现金470,894,532.14298,455,564.391,466,910.5481,409,219.46
  支付给职工以及为职工支付的现金184,349,089.66125,519,354.3966,547,567.8226,997,998.09
  支付的各项税费107,403,799.7465,249,909.4930,434,417.2483,074,449.65
  支付其他与经营活动有关的现金205,579,031.18136,318,089.9263,896,587.39283,752,937.3
  经营活动现金流出小计968,226,452.72625,542,918.1252,345,482.931,075,234,604.5
  经营活动产生的现金流量净额200,926,361.51133,785,759.65120,667,925.66156,568,029.75
二、投资活动产生的现金流量:
  收回投资收到的现金1,966,407.291,249,298.081,007,422.444,170,068.44
  取得投资收益收到的现金13,066,793.119,171,840.635,574,435.320,264,316.48
  处置固定资产、无形资产和其他长期资产收回的现金净额60,63045,000-11,000
  收到的其他与投资活动有关的现金1,224,233,971.21833,200,005.7406,700,0001,269,100,000
  投资活动现金流入小计1,239,327,801.61843,666,144.41413,281,857.741,293,545,384.92
  购建固定资产、无形资产和其他长期资产支付的现金91,014,217.7274,638,919.8551,537,554.37218,872,538.99
  投资支付的现金12,000,0005,000,000--
  取得子公司及其他营业单位支付的现金---870,000
  支付其他与投资活动有关的现金1,190,728,382.77876,082,505.7446,159,6001,321,186,400
  投资活动现金流出小计1,293,742,600.49955,721,425.55497,697,154.371,540,928,938.99
  投资活动产生的现金流量净额-54,414,798.88-112,055,281.14-84,415,296.63-247,383,554.07
三、筹资活动产生的现金流量:
  吸收投资收到的现金157,149,999.6157,149,999.6--
  取得借款收到的现金189,608,852149,608,852111,571,816518,678,138
  筹资活动现金流入小计346,758,851.6306,758,851.6111,571,816518,678,138
  偿还债务支付的现金278,571,955.43139,563,03253,000,000361,885,717.6
  分配股利、利润或偿付利息支付的现金45,064,078.977,260,4703,378,714.7637,421,234.47
  支付其他与筹资活动有关的现金18,082,339.7212,808,624.95,564,625.312,035,922.29
  筹资活动现金流出小计341,718,374.12159,632,126.961,943,340.06411,342,874.36
  筹资活动产生的现金流量净额5,040,477.48147,126,724.749,628,475.94107,335,263.64
四、汇率变动对现金及现金等价物的影响-4,091,263.48-2,845,111.38-1,731,670.8-1,819,544.12
五、现金及现金等价物净增加额147,460,776.63166,012,091.8384,149,434.1714,700,195.2
  加:期初现金及现金等价物余额231,767,897.8231,767,897.8231,767,897.8217,067,702.6
  期末现金及现金等价物余额379,228,674.43397,779,989.63315,917,331.97231,767,897.8
补充资料:
  净利润-85,171,658.82-88,648,072.01
  资产减值准备-1,388,578.78-13,339,579.74
  固定资产和投资性房地产折旧-42,557,734.62-82,057,739.66
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-42,557,734.62-82,057,739.66
  无形资产摊销-7,365,163.41-14,155,252.27
  长期待摊费用摊销-2,948,170.09-5,340,279.97
  处置固定资产、无形资产和其他长期资产的损失---1,229,172.24
  固定资产报废损失-443,814.93-639,768.73
  公允价值变动损失--2,208,188.6--53,436,304.56
  财务费用-8,733,398.42-41,170,506.72
  投资损失--9,519,347.89--8,067,847.7
  递延所得税--2,975,826.4-8,152,321.75
  其中:递延所得税资产减少--1,620,988.25--1,413,549.79
    递延所得税负债增加--1,354,838.15-9,565,871.54
  存货的减少--29,741,966.04--24,088,334.62
  经营性应收项目的减少-18,478,943.15--105,110,135.1
  经营性应付项目的增加-18,303,217.22-96,067,886.92
  其他--7,380,472.1--4,631,331.39
  融资租入固定资产---1,982,980.7
  现金的期末余额-397,779,989.63-231,767,897.8
  减:现金的期初余额-231,767,897.8-217,067,702.6
  现金及现金等价物的净增加额-166,012,091.83-14,700,195.2
公告日期2026-10-282026-08-252026-04-292026-04-22
审计意见(境内)标准无保留意见
TOP↑